As of January 22, 2025, Curis (CRIS) has a market cap of $27.687 million USD. According to our data, Curis is ranked No.8461 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $27.69 M |
6.86%
|
Dec 31, 2024 | $25.91 M |
-76.00%
|
Dec 29, 2023 | $0.11 B |
2,218.18%
|
Dec 30, 2022 | $4.66 M |
-88.45%
|
Dec 31, 2021 | $40.30 M |
-41.88%
|
Dec 31, 2020 | $69.34 M |
381.76%
|
Dec 31, 2019 | $14.39 M |
146.38%
|
Dec 31, 2018 | $5.84 M |
-80.29%
|
Dec 29, 2017 | $29.63 M |
-77.27%
|
Dec 30, 2016 | $0.13 B |
5.84%
|
Dec 31, 2015 | $0.12 B |
94.00%
|
Dec 31, 2014 | $63.50 M |
-46.81%
|
Dec 31, 2013 | $0.12 B |
-17.78%
|
Dec 31, 2012 | $0.15 B |
-26.71%
|
Dec 30, 2011 | $0.20 B |
136.36%
|
Dec 31, 2010 | $83.82 M |
-39.08%
|
Dec 31, 2009 | $0.14 B |
333.33%
|
Dec 31, 2008 | $31.75 M |
-23.47%
|
Dec 31, 2007 | $41.49 M |
-22.22%
|
Dec 29, 2006 | $53.34 M |
-64.51%
|
Dec 30, 2005 | $0.15 B |
-31.99%
|
Dec 31, 2004 | $0.22 B |
16.00%
|
Dec 31, 2003 | $0.19 B |
336.89%
|
Dec 31, 2002 | $43.60 M |
-81.64%
|
Dec 31, 2001 | $0.24 B |
-36.79%
|
Dec 29, 2000 | $0.38 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Blueprint Medicines
BPMC
|
$7.06 B |
-0.000 M
|
USA
|
Exelixis
EXEL
|
$9.39 B |
0.000 M
|
USA
|
Incyte
INCY
|
$13.95 B |
-0.000 M
|
USA
|
Agios Pharmaceuticals
AGIO
|
$1.94 B |
-0.000 M
|
USA
|
Array Technologies
ARRY
|
$0.97 B |
0.000 M
|
USA
|
Deciphera Pharmaceuticals
DCPH
|
$2.21 B |
2.213 B
|
USA
|
Karyopharm Therapeutics
KPTI
|
$84.09 M |
0.000 M
|
USA
|
MacroGenics
MGNX
|
$0.19 B |
-0.000 M
|
USA
|
Zymeworks
ZYME
|
$1.01 B |
-0.000 M
|
Canada
|
Iovance Biotherapeutics
IOVA
|
$1.83 B |
-0.000 M
|
USA
|
Syndax Pharmaceuticals
SNDX
|
$1.20 B |
0.000 M
|
USA
|
TG Therapeutics
TGTX
|
$4.54 B |
0.000 M
|
USA
|
Xencor
XNCR
|
$1.45 B |
0.000 M
|
USA
|
Market Cap | = | CRIS Stock Price | * | CRIS Shares Outstanding |
= | $3.27 | * | 8.47 M | |
= | $27.69 M |